SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SARS and Avian Flu

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (792)5/12/2003 10:09:55 PM
From: IRWIN JAMES FRANKEL  Read Replies (1) of 4232
 
Richard,

What about fowl pigma?

"In fact, the innate system does such a great job that most rhinovirus infections are over in just a few days -- long before the adaptive immune system can really get cranked up.

Because rhinovirus 'surrenders' so soon after infection, the adaptive immune system usually doesn't become fully activated. As a result, neutralizing antibodies generally are not made in sufficient quantities to protect against a subsequent rhinovirus attack -- even by the same strain."

pg 27 "How Pathogenic Viruses Work", Lauren Sompayrac, PhD Retired Professor, Dept of Molecular, Cellular and Development Biology, University of Colorado at Boulder

One of Torbens students, :-)

ij
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext